Paper Details
- Home
- Paper Details
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model.
Author: BergeriaCecilia L, CampbellClaudia M, DunnKelly E, HuhnAndrew S, MunChung Jung, SpeedTraci J, VandreyRyan
Original Abstract of the Article :
This Phase II study evaluated analgesia, abuse liability, and cognitive performance of hydromorphone and oral delta-9-tetrahydrocannabinol (THC; dronabinol) using a within-subject, double-blind, randomized, placebo-controlled, human laboratory trial. Healthy adults (N = 29) with no history of drug u...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055479/
データ提供:米国国立医学図書館(NLM)
Dronabinol and Hydromorphone: Exploring the Potential of a New Pain Relief Duo
The search for effective pain relief is a never-ending quest. This research investigates the combined effects of dronabinol (a cannabinoid) and hydromorphone (an opioid) in a human laboratory pain model. It's like exploring a new desert oasis, seeking a combination of natural resources to provide sustenance and relief.
A Complex Interaction: Dronabinol and Hydromorphone
The study found that the combination of dronabinol and hydromorphone had varying effects on analgesia and abuse liability. While a low dose of dronabinol (2.5mg) seemed to enhance hydromorphone's analgesic effects, higher doses increased the risk of abuse and adverse effects. It's like blending different types of sand to create a unique mixture, but finding the right proportions is crucial for stability.
Navigating Pain Management with Caution
This research highlights the complex interactions between cannabinoids and opioids, emphasizing the importance of individualized treatment approaches and careful monitoring. It's like learning to navigate a desert with different types of terrain, requiring flexibility and adaptability. Further research is needed to optimize the use of these drugs for pain relief, ensuring a safe and effective journey.
Dr.Camel's Conclusion
This research delves into the potential of combining cannabinoids and opioids for pain management. It highlights the importance of understanding the complex interactions between these drugs and the need for individualized treatment approaches. It's a reminder that the quest for effective pain relief requires a careful and nuanced approach, considering both potential benefits and risks. It's like navigating a desert with a mix of treacherous sand dunes and lush oases, requiring a steady hand and a discerning eye.
Date :
- Date Completed 2021-06-28
- Date Revised 2023-01-31
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.